Announcements Trials

Browse Landscape

Status

Completed 8 Unknown 4 Recruiting 4 Active not recruiting 3 Terminated 2 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

the Rate of Participation in Screening for PBC 1

Interventions

Observation 23 Blood Specimen Collection 20 Drug Therapy 14 Surveys and Questionnaires 10 Surgical Procedures, Operative 8 Immune Checkpoint Inhibitors 8 Immunotherapy 7 Positron Emission Tomography Computed Tomography 5 Hematologic Tests 5 Watchful Waiting 4 Neoadjuvant Therapy 4 Fluorodeoxyglucose F18 4 Bevacizumab 4 tislelizumab 3 envafolimab 3 darolutamide 3 Tyrosine Kinase Inhibitors 3 Therapeutics 3 Standard of Care 3 Radiotherapy 3 Letrozole 3 Indocyanine Green 3 Imatinib Mesylate 3 Endosonography 3 Endoscopic Mucosal Resection 3 Docetaxel 3 Cyclophosphamide 3 Capecitabine 3 Artificial Intelligence 3 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Observational × Mass Screening × Clear all

NCT05440123 2025-06-12

LUMASCAN-2

Centre Hospitalier Intercommunal Creteil

Not yet recruiting

the Rate of Participation in Screening for PBC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡